ArticleDiabetes, obesity & metabolism2026

Risk of Psychiatric Worsening With GLP-1 Receptor Agonist Use in Patients With Type 2 Diabetes and Treated Depression.

Yu Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.